These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 1391614)

  • 1. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine.
    Turesky RJ; Rossi SC; Welti DH; Lay JO; Kadlubar FF
    Chem Res Toxicol; 1992; 5(4):479-90. PubMed ID: 1391614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5- f]quinoline at the C-8 and N2 atoms of guanine.
    Turesky RJ; Markovic J
    Chem Res Toxicol; 1994; 7(6):752-61. PubMed ID: 7696529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry.
    Paehler A; Richoz J; Soglia J; Vouros P; Turesky RJ
    Chem Res Toxicol; 2002 Apr; 15(4):551-61. PubMed ID: 11952342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys.
    Snyderwine EG; Davis CD; Nouso K; Roller PP; Schut HA
    Carcinogenesis; 1993 Jul; 14(7):1389-95. PubMed ID: 8330355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation and differential removal of C-8 and N2-guanine adducts of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in the liver, kidney, and colorectum of the rat.
    Turesky RJ; Markovic J; Aeschlimann JM
    Chem Res Toxicol; 1996 Mar; 9(2):397-402. PubMed ID: 8839041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA adduct formation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay.
    Turesky RJ; Gremaud E; Markovic J; Snyderwine EG
    Chem Res Toxicol; 1996 Mar; 9(2):403-8. PubMed ID: 8839042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of DNA adducts by the food mutagen 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline (4,8-DiMeIQx) in vitro and in vivo. Identification of a N2-(2'-deoxyguanosin-8-yl)-4,8-DiMeIQx adduct.
    Frandsen H; Grivas S; Turesky RJ; Andersson R; Dragsted LO; Larsen JC
    Carcinogenesis; 1994 Nov; 15(11):2553-8. PubMed ID: 7955105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and reactivity of 2-nitrosoamino-3,8-dimethylimidazo[4,5-f]quinoxaline.
    Lakshmi VM; Hsu FF; Schut HA; Zenser TV
    Chem Res Toxicol; 2006 Feb; 19(2):325-33. PubMed ID: 16485910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline in the rat and nonhuman primates.
    Turesky RJ; Box RM; Markovic J; Gremaud E; Snyderwine EG
    Mutat Res; 1997 May; 376(1-2):235-41. PubMed ID: 9202760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification.
    Pfau W; Brockstedt U; Söhren KD; Marquardt H
    Carcinogenesis; 1994 May; 15(5):877-82. PubMed ID: 8200090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-C8-MeIQx) in human tissues.
    Totsuka Y; Fukutome K; Takahashi M; Takahashi S; Tada A; Sugimura T; Wakabayashi K
    Carcinogenesis; 1996 May; 17(5):1029-34. PubMed ID: 8640908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: a conformational analysis of its major DNA adduct and comparison with the 2-amino-3-methylimidazo[4,5-f]quinoline adduct.
    Gauvin J; Broyde S; Shapiro R
    Chem Res Toxicol; 2001 May; 14(5):476-82. PubMed ID: 11368544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in liver, kidney and colo-rectum of rats.
    Turesky RJ; Markovic J
    Carcinogenesis; 1995 Sep; 16(9):2275-9. PubMed ID: 7554091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats.
    Davis CD; Schut HA; Snyderwine EG
    Carcinogenesis; 1993 Oct; 14(10):2091-6. PubMed ID: 8222059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx).
    Metry KJ; Neale JR; Doll MA; Howarth AL; States JC; McGregor WG; Pierce WM; Hein DW
    Mutat Res; 2010 Feb; 684(1-2):66-73. PubMed ID: 20004212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
    Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
    Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the food-borne carcinogens 2-amino-3-methylimidazo-[4,5-f]quinoline and 2-amino-3,8- dimethylimidazo[4,5-f]-quinoxaline in the rat as a model for human biomonitoring.
    Turesky RJ; Stillwell WG; Skipper PL; Tannenbaum SR
    Environ Health Perspect; 1993 Mar; 99():123-8. PubMed ID: 8319609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
    Metry KJ; Neale JR; Bendaly J; Smith NB; Pierce WM; Hein DW
    Drug Metab Dispos; 2009 Nov; 37(11):2123-6. PubMed ID: 19666988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
    Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
    Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethyl-imidazo[4,5- f]quinoxaline 3',5'-diphosphate, a major DNA adduct, detected by nuclease P1 modification of the 32P-postlabeling method, in the liver of rats fed MeIQx.
    Ochiai M; Nagaoka H; Wakabayashi K; Tanaka Y; Kim SB; Tada A; Nukaya H; Sugimura T; Nagao M
    Carcinogenesis; 1993 Oct; 14(10):2165-70. PubMed ID: 8222070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.